Concepedia

Ulrich Kube

UK

Statistics

Publications

4

Citations

74

H-Index

4

Active since

2013

Affiliations

Klinikum Chemnitz(Current)

Goethe University Frankfurt

Novartis (Germany)

Charité - Universitätsmedizin Berlin

University Hospital Frankfurt

Ulrich Kube is an author at Klinikum Chemnitz specializing in vascular endothelial growth factor inhibition, metastatic disease treatment, and metastasis.

Publications per year

2013–2015

4

Publications

4

Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: final results of a noninterventional study

Lothar Bergmann, Ulrich Kube, Christian Doehn et al. · BMC Cancer · 2015 · 23 citations · Full text

, , +17

Everolimus for patients with metastatic renal cell carcinoma refractory to anti-VEGF therapy: Results of a pooled analysis of non-interventional studies

Laurence Albigès, Ulrich Kube, Jean‐Christophe Eymard et al. · European Journal of Cancer · 2015 · 20 citations

, , +16

Therapy of mRCC beyond mTOR-inhibition in clinical practice: results of a retrospective analysis

Luise Maute, Viktor Grünwald, Steffen Weikert et al. · Journal of Cancer Research and Clinical Oncology · 2014 · 16 citations · Full text

, , +7

Everolimus in Metastatic Renal Cell Carcinoma after Failure of Initial Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor (VEGFr-TKI) Therapy: Results of an Interim Analysis of a Non-Interventional Study

Lothar Bergmann, Peter J. Goebell, Ulrich Kube et al. · Oncology Research and Treatment · 2013 · 15 citations · Full text

, , +17

1–4 of 4